logo of the EU drugs agency

You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table TDI-11. Age at first use of primary drug among clients according to primary drug for which they enter treatment — EU summary of clients entering treatment, 2007 or most recent year available [see all tables in this series...]

Part (viii) All inpatient clients, primary drug distribution by age at first use (%)

Substance<1515–1920–2425–2930–3435–3940–4445+Age knownAge not known
Opiates28.255.766.968.161.956.548.635.311611931
Cocaine2.14.06.97.69.510.65.31.6105683
Stimulants19.919.512.910.29.67.77.36.13423312
Hypnotics and sedatives4.13.13.65.410.814.926.944.31052237
Hallucinogens0.30.20.20.00.00.20.00.0333
Volatile substances6.21.40.30.40.20.20.00.034625
Cannabis 37.115.07.66.55.05.64.53.93114265
Other substances 2.21.21.41.82.94.37.38.7372131
Total2960969446651837853444245109210071987

Notes:

 : indicates data not available 

 Countries reporting data: BE, BG, CZ, DK, DE, IE, EL, FR, CY, LV, LU, AT, RO, SK, FI, SE, HR, TR. 

 Last data available from Belgium refer to 2005. 

 The number of treatment clients in each country is listed in Table TDI-7

 See also Table TDI-109 on distribution by country and ‘General notes for interpreting data’ on the Explanatory notes and help page

Sources:

 Reitox national reports 2008 — Table TDI — inpatient treatment centres. 

(see the help page for information about formats etc.)

Page last updated: Tuesday, 30 June 2009